SILINGARDI, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 7.793
EU - Europa 4.270
AS - Asia 3.831
SA - Sud America 505
AF - Africa 100
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 8
Totale 16.534
Nazione #
US - Stati Uniti d'America 7.636
IT - Italia 1.254
GB - Regno Unito 1.131
SG - Singapore 1.080
CN - Cina 1.078
SE - Svezia 452
HK - Hong Kong 413
BR - Brasile 366
VN - Vietnam 364
DE - Germania 273
FI - Finlandia 245
UA - Ucraina 231
TR - Turchia 219
FR - Francia 192
RU - Federazione Russa 183
BD - Bangladesh 161
IN - India 114
KR - Corea 88
BG - Bulgaria 73
CA - Canada 68
ID - Indonesia 53
AR - Argentina 44
NL - Olanda 42
MX - Messico 38
IQ - Iraq 31
MY - Malesia 31
ES - Italia 28
PK - Pakistan 28
ZA - Sudafrica 28
CO - Colombia 26
PL - Polonia 26
AU - Australia 24
JP - Giappone 24
SA - Arabia Saudita 21
BZ - Belize 19
EC - Ecuador 19
CL - Cile 18
IE - Irlanda 18
RO - Romania 18
CZ - Repubblica Ceca 17
BE - Belgio 16
AE - Emirati Arabi Uniti 15
IR - Iran 15
AT - Austria 13
KE - Kenya 13
NP - Nepal 13
PH - Filippine 13
MA - Marocco 12
VE - Venezuela 12
ET - Etiopia 11
CR - Costa Rica 10
LT - Lituania 10
EG - Egitto 9
TH - Thailandia 9
CH - Svizzera 8
DZ - Algeria 7
EU - Europa 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
JO - Giordania 6
KZ - Kazakistan 6
PE - Perù 6
PY - Paraguay 6
TW - Taiwan 6
AZ - Azerbaigian 5
DK - Danimarca 5
GE - Georgia 5
IL - Israele 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
JM - Giamaica 4
MD - Moldavia 4
RS - Serbia 4
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
CM - Camerun 3
KG - Kirghizistan 3
MK - Macedonia 3
PR - Porto Rico 3
TT - Trinidad e Tobago 3
AN - Antille olandesi 2
LB - Libano 2
LK - Sri Lanka 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
GF - Guiana Francese 1
GH - Ghana 1
Totale 16.514
Città #
Santa Clara 844
Southend 778
Ashburn 686
Singapore 670
Fairfield 493
Chandler 455
Jacksonville 433
Hong Kong 395
Hefei 380
San Jose 372
Woodbridge 320
Dearborn 318
Council Bluffs 300
Houston 243
Wilmington 225
Nyköping 212
Ann Arbor 203
Beijing 199
Cambridge 192
Helsinki 164
Seattle 161
London 158
Los Angeles 148
Izmir 113
The Dalles 107
Ho Chi Minh City 106
Milan 101
Buffalo 95
New York 92
Princeton 86
Hanoi 82
Chicago 80
Seoul 80
San Diego 73
Eugene 71
Sofia 71
Rome 67
Des Moines 63
Lauterbourg 57
Columbus 56
Moscow 51
Jakarta 45
Dong Ket 44
Falls Church 39
Shanghai 34
São Paulo 32
Bremen 31
Orem 29
Munich 26
Salt Lake City 26
Naples 25
Dallas 23
Turin 23
Da Nang 22
Redwood City 21
Belize City 19
Chennai 19
Tokyo 19
Modena 18
Phoenix 18
Bari 17
Frankfurt am Main 17
Norwalk 17
Palermo 17
Toronto 17
Brussels 16
Guangzhou 16
Montreal 16
Baghdad 14
Mexico City 14
Verona 14
Warsaw 14
Bologna 13
Brno 13
Buraidah 13
Dublin 13
Falkenstein 13
Johannesburg 13
Saint Petersburg 13
San Mateo 13
Tampa 13
Turku 13
Florence 12
Nanjing 12
Ottawa 12
Saint Louis 12
Boardman 11
Brooklyn 11
Kunming 11
Elk Grove Village 10
Haiphong 10
Madrid 10
Philadelphia 10
Denver 9
Kent 9
Livorno 9
Nairobi 9
Rio de Janeiro 9
Torino 9
Washington 9
Totale 10.816
Nome #
Sindrome mediastinica da mieloblastoma quale manifestazione d'esordio di leucemia mieloide acuta 777
The italian multi-center project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk 558
Il morbo di Hodgkin sclero-nodulare. Studio clinico-patologico 487
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 387
Italian family with two independent mutations:3358T/A in BRCA1 and 8756delA in BRCA2 genes. 345
Patogenesi complessa di una emopatia sistemica: la tricoleucemia 344
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 315
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease - A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 314
PROMECE-CYTABOM VS MACOP-B IN ADVANCED AGGRESSIVE NON-HODGKINS-LYMPHOMA - LONG-TERM RESULTS OF A MULTICENTER STUDY OF THE ITALIAN LYMPHOMA STUDY-GROUP (GISL) 312
Effects of thymostimulin with combination chemotherapy in patients with aggressive non-Hodgkin's lymphoma. 307
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: The Gruppo Italiano per lo Studio dei Linfomi Experience 302
Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting 301
A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER STUDY COMPARING A LEVOSULPIRIDE-BASED AND A METOCLOPRAMIDE-BASED COMBINATION IN THE PREVENTION OF PROMECE-CYTABOM-INDUCED EMESIS 300
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 299
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer 292
EPIDOXORUBICIN VS IDARUBICIN CONTAINING REGIMENS IN INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA - PRELIMINARY-RESULTS OF A MULTICENTRIC RANDOMIZED TRIAL 286
A report of seven long survivors for evidence of prognostic factors in hairy cell leukemia 281
A pilot study on the use of the ProMACE CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma 280
STIFF-MAN SYNDROME IN A PATIENT WITH HODGKINS-DISEASE - AN UNUSUAL PARANEOPLASTIC SYNDROME 277
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 276
Retrospective analysis of mantle cell lymphoma: experience of the Gruppo Italiano per lo Studio dei Linfomi (GISL) 266
Hereditary risk of breast cancer: not only brca 251
Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171) 250
Alimentazione e tumori II. Le vitamine 249
A multicenter randomized trial of two different ProMACE-CytaBOM derived protocols in aggressive non-Hodgkin's Lymphomas (NHL). A preliminary report 247
Bone marrow infiltration in Hairy cell leukemia after interferon therapy detected by magnetic resonance imagin 246
Complete remission in a case of aplastic anemia after treatment with antilymphocyte globulin 244
ANAPLASTIC LARGE-CELL LYMPHOMA (CD30+/KI-1+) - ANALYSIS OF 35 CASES FOLLOWED AT GISL CENTERS 244
Leucemia e tricoleucociti: studio clinico patologico di 30 casi 242
Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study 242
Hodgkin's disease prognosis: a directly predictive equation 239
HAIRY-CELL LEUKEMIA - A CLINICAL REVIEW BASED ON 725 CASES OF THE ITALIAN-COOPERATIVE-GROUP (ICGHCL) 239
Trapianto di midollo osseo nelle aplasie midollari. 237
Detection of bone marrow involvement in patients with cancer 236
Castleman's lymphoadenopathy: twenty years of observation. I. General considerations. Monodenopathic variety 230
Profilassi del vomito nei pazienti affetti da linfoma non-Hodgkin trattati con il protocollo ProMECE-CytaBOM. Risultati preliminari di uno studio clinico controllato 227
Prevention of cisplatin induced vomiting in patients with cancer. A pilot study with a multiagent protocol 227
Usefulness of breast MRI in a patient with genetic risk 224
Validation of the international prognostic index in working formulation group a low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo studio dei linfomi registry. 223
Studio clinico immunologico di sei casi di morbo di Behcet 216
Long-term results from MOPPEBVCAD chemotherapy with optional limited radiotherapy in advanced Hodgkin's disease 214
Screening clinico, mammografico e genetico del carcinoma mammario ereditario 213
Castleman's lymphoadenopathy: twenty years of observation. II. Generalized form 213
Hodgkin's disease presenting below the diaphragm. The experience of the Gruppo Italiano Studio Linfomi (GISL) 210
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavourably presenting Hodgkin's disease. A report from the Italian Lymphoma Study Group 208
Alimentazione e tumori I. Considerazioni dietetiche generali: gli alimenti 206
Human lymphoblastoid interferon as initial therapy in hairy cell leukemia: a multicenter study in non-splenectomized patients 206
Alimentazione e tumori III. Gli oligoelementi 201
Istiocitosi maligna 200
Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL 198
Utilità della Risonanza Magnetica Nucleare nello studio del midollo osseo di pazienti affetti da hairy Cell Leukemia 198
Hairy cell leukemia: a reversible disease? A report of two cases of spontaneous remission 197
Relationship between prognostic factors and therapy in high grade non Hodgkin's lymphomas over two decades 195
The excretion of tryptophan metabolites in patients with different forms of haemoblastosis 189
Utilità diagnostica della risonanza magnetica nucleare in onco-ematologia 181
Gli interferoni in terapia antineoplastica 180
PROMACE-CYTABOM VERSUS MACOP-B IN INTERMEDIATE AND HIGH-GRADE NHL - PRELIMINARY-RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL 180
Ruolo attuale della chemioterapia nel carcinoma transizionale della vescica muscolo-invasivo 174
Cancer Incidence in the Province of Modena. Cancer Incidence in Five Continents Vol.VII 173
Free from failure survival in Hodgkin's disease. Long term analysis of 148 cases treated with a MOPP modified protocol 171
La chemioprevenzione del carcinoma mammario 168
REGIMEN-RELATED LIVER TOXICITY IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 162
METHOTREXATE, VINBLASTINE, EPIDOXORUBICIN AND CISPLATIN (M-VEC) IN PATIENTS WITH LOCALLY ADVANCED TRANSITIONAL BLADDER-CANCER 159
La strategia terapeutica del GISL nei linfomi non-Hodgkin 156
La predisposizione genetica al cancro dell'ovaio. Individuazione e sorveglianza delle donne a rischio 144
Immunohistochemical labeling index in breast cancer after in vivo administration of bromodeoxiuridine 135
Emopoiesi extramidollare endotoracica in Morbo di Cooley dell'adulto 124
Totale 16.774
Categoria #
all - tutte 55.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 0 0 125
2021/20221.294 28 159 111 129 40 105 72 64 149 73 223 141
2022/20231.403 123 130 109 125 180 238 18 131 173 24 58 94
2023/2024826 44 45 50 84 147 68 143 66 9 34 35 101
2024/20252.874 117 39 50 222 609 422 221 201 319 84 279 311
2025/20265.017 298 264 506 362 569 477 569 218 544 473 436 301
Totale 16.774